Bellevue Group’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-149,000
| Closed | -$2.59M | – | 223 |
|
|
2020
Q4 | $2.59M | Sell |
149,000
-1,254,400
| -89% | -$21.8M | 0.03% | 139 |
|
|
2020
Q3 | $25.7M | Buy |
1,403,400
+246,000
| +21% | +$4.51M | 0.36% | 77 |
|
|
2020
Q2 | $20.7M | Buy |
1,157,400
+1,108,900
| +2,286% | +$19.8M | 0.29% | 78 |
|
|
2020
Q1 | $787K | Sell |
48,500
-100,000
| -67% | -$1.62M | 0.02% | 146 |
|
|
2019
Q4 | $2.67M | Sell |
148,500
-52,935
| -26% | -$953K | 0.04% | 124 |
|
|
2019
Q3 | $4.08M | Buy |
201,435
+34,800
| +21% | +$705K | 0.08% | 115 |
|
|
2019
Q2 | $3.68M | Sell |
166,635
-150,500
| -47% | -$3.33M | 0.06% | 115 |
|
|
2019
Q1 | $4.33M | Sell |
317,135
-41,800
| -12% | -$570K | 0.24% | 81 |
|
|
2018
Q4 | $3.25M | Buy |
358,935
+143,000
| +66% | +$1.29M | 0.21% | 84 |
|
|
2018
Q3 | $3.56M | Buy |
215,935
+18,100
| +9% | +$299K | 0.23% | 88 |
|
|
2018
Q2 | $2.77M | Buy |
197,835
+47,835
| +32% | +$670K | 0.24% | 77 |
|
|
2018
Q1 | $1.66M | Hold |
150,000
| – | – | 0.16% | 88 |
|
|
2017
Q4 | $1.32M | Buy |
+150,000
| New | +$1.32M | 0.14% | 98 |
|
|
2017
Q2 | – | Sell |
-175,000
| Closed | -$3.7M | – | 135 |
|
|
2017
Q1 | $3.7M | Hold |
175,000
| – | – | 0.49% | 58 |
|
|
2016
Q4 | $4.93M | Sell |
175,000
-27,000
| -13% | -$760K | 1.01% | 33 |
|
|
2016
Q3 | $5.41M | Sell |
202,000
-102,000
| -34% | -$2.73M | 0.98% | 38 |
|
|
2016
Q2 | $5.14M | Buy |
304,000
+17,000
| +6% | +$287K | 0.97% | 37 |
|
|
2016
Q1 | $6.09M | Buy |
+287,000
| New | +$6.09M | 1.11% | 30 |
|